Recent TRVI Stock Price | TRVI Stock Predictions | |
$2.69 | +175.09% |
$7.40 |
Recent TRVI Analyst Ratings Breakdown, Making TRVI Stock Predictions | ||||
---|---|---|---|---|
Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | |
Strong buy ratings: | 4 | 4 | 4 | 4 |
Buy ratings: | 1 | 1 | 1 | 1 |
Hold ratings: | 0 | 0 | 0 | 0 |
Sell ratings: | 0 | 0 | 0 | 0 |
Strong sell ratings: | 0 | 0 | 0 | 0 |
Average rating: | 1.2 | 1.2 | 1.2 | 1.2 |
For the TRVI stock predictions from the analysts covering Trevi Therapeutics Inc, we have collected all of the individual TRVI stock predictions for stock price one year from now (i.e. each analyst's "forward price target") and at the top of this page we have presented the average prediction across the 5 different analysts covering TRVI (as reported in
data provided by Zacks Investment Research via Quandl.com).
But since TRVI stock predictions may vary widely, another useful metric to consider is the median TRVI stock prediction, which represents the price at which half of the analysts
made TRVI stock predictions that were higher and half made TRVI stock predictions that were lower. This makes for a different take on the TRVI stock predictions out there, as compared to average or mean.
And that median across all the individual TRVI stock predictions was: $8.0 as of 2024-04-19.
The very highest of the TRVI stock predictions for one year price target was $9.0, while the very lowest of the TRVI stock predictions in the analyst group was
$6.0 (with a standard deviation of $1.341). Get the latest Zacks research report on TRVI — FREE
Find out: TRVI next earnings date »
Dividend Growth Stocks: 25 Aristocrats
10 Dividend Bargains You Can Buy Cheaper Than Insiders Did
Other stock predictions:
LAC Stock Predictions
REX Stock Predictions
ALXN Stock Predictions
CTO Stock Predictions
ELOX Stock Predictions
PAAS Stock Predictions
MTRX Stock Predictions
IMRA Stock Predictions
TSLX Stock Predictions
|
|
Strong Buy (3.80 out of 4) 100th percentile
(ranked higher than approx. 100% of all stocks covered)
Based on data provided by Zacks Investment Research via Quandl.com |